Human albumin enhances the pathogenic potential of Candida glabrata on vaginal epithelial cells.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
10 2021
Historique:
received: 23 07 2021
accepted: 15 10 2021
revised: 09 11 2021
pubmed: 29 10 2021
medline: 27 11 2021
entrez: 28 10 2021
Statut: epublish

Résumé

The opportunistic pathogen Candida glabrata is the second most frequent causative agent of vulvovaginal candidiasis (VVC), a disease that affects 70-75% of women at least once during their life. However, C. glabrata is almost avirulent in mice and normally incapable of inflicting damage to vaginal epithelial cells in vitro. We thus proposed that host factors present in vivo may influence C. glabrata pathogenicity. We, therefore, analyzed the impact of albumin, one of the most abundant proteins of the vaginal fluid. The presence of human, but not murine, albumin dramatically increased the potential of C. glabrata to damage vaginal epithelial cells. This effect depended on macropinocytosis-mediated epithelial uptake of albumin and subsequent proteolytic processing. The enhanced pathogenicity of C. glabrata can be explained by a combination of beneficial effects for the fungus, which includes an increased access to iron, accelerated growth, and increased adhesion. Screening of C. glabrata deletion mutants revealed that Hap5, a key regulator of iron homeostasis, is essential for the albumin-augmented damage potential. The albumin-augmented pathogenicity was reversed by the addition of iron chelators and a similar increase in pathogenicity was shown by increasing the iron availability, confirming a key role of iron. Accelerated growth not only led to higher cell numbers, but also to increased fungal metabolic activity and oxidative stress resistance. Finally, the albumin-driven enhanced damage potential was associated with the expression of distinct C. glabrata virulence genes. Transcriptional responses of the epithelial cells suggested an unfolded protein response (UPR) and ER-stress responses combined with glucose starvation induced by fast growing C. glabrata cells as potential mechanisms by which cytotoxicity is mediated.Collectively, we demonstrate that albumin augments the pathogenic potential of C. glabrata during interaction with vaginal epithelial cells. This suggests a role for albumin as a key player in the pathogenesis of VVC.

Identifiants

pubmed: 34710198
doi: 10.1371/journal.ppat.1010037
pii: PPATHOGENS-D-21-01537
pmc: PMC8577789
doi:

Substances chimiques

Albumins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1010037

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Res Med Sci. 2017 Dec 26;22:132
pubmed: 29387119
Diabetol Metab Syndr. 2011 Jun 15;3(1):11
pubmed: 21676260
Sci Rep. 2017 Jun 14;7(1):3531
pubmed: 28615656
J Fungi (Basel). 2018 May 20;4(2):
pubmed: 29783771
Mol Cell Proteomics. 2010 Sep;9(9):2063-75
pubmed: 20811074
FEMS Yeast Res. 2019 Mar 1;19(2):
pubmed: 30689833
PLoS Pathog. 2014 Oct 02;10(10):e1004407
pubmed: 25275454
Curr Microbiol. 2019 Aug;76(8):950-953
pubmed: 29332139
Int Rev Cell Mol Biol. 2013;301:215-90
pubmed: 23317820
J Eukaryot Microbiol. 1994 Jan-Feb;41(1):78-85
pubmed: 8124270
Microbiology (Reading). 2002 Aug;148(Pt 8):2599-2606
pubmed: 12177354
Mycoses. 2014 Dec;57 Suppl 3:13-7
pubmed: 25178879
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Oct;94(4):432-8
pubmed: 12374915
J Lipid Res. 2019 Jun;60(6):1087-1098
pubmed: 31015253
Sci Rep. 2020 Oct 13;10(1):17074
pubmed: 33051479
Hepatology. 2011 Mar;53(3):875-84
pubmed: 21374660
Rev Iberoam Micol. 2017 Oct - Dec;34(4):203-210
pubmed: 29032925
Cell Rep. 2015 May 5;11(5):737-47
pubmed: 25921529
Mol Microbiol. 2013 Apr;88(2):371-81
pubmed: 23448689
Front Immunol. 2019 Jan 04;9:3083
pubmed: 30662442
J Biol Chem. 2011 Jan 28;286(4):2469-76
pubmed: 21098039
J Lab Physicians. 2014 Jan;6(1):28-30
pubmed: 24696557
mBio. 2018 Jul 31;9(4):
pubmed: 30065091
Drug Metab Pharmacokinet. 2012;27(3):336-43
pubmed: 22214936
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
BMC Infect Dis. 2002;2:1
pubmed: 11835694
Cell Host Microbe. 2020 Mar 11;27(3):454-466.e8
pubmed: 32075740
Cancer Res. 2017 Nov 1;77(21):5925-5937
pubmed: 28923854
Sci Rep. 2016 Mar 02;6:22538
pubmed: 26932729
Bioinformatics. 2014 Feb 01;30(3):301-4
pubmed: 24319002
Nat Microbiol. 2021 May;6(5):643-657
pubmed: 33753919
Probiotics Antimicrob Proteins. 2021 Feb;13(1):163-172
pubmed: 32583131
Genome Biol. 2014;15(12):550
pubmed: 25516281
IUBMB Life. 2005 Nov;57(11):749-59
pubmed: 16511968
J Am Soc Nephrol. 2004 Jul;15(7):1920-6
pubmed: 15213282
PLoS One. 2016 Jan 25;11(1):e0147969
pubmed: 26807975
J Immunol. 2008 Dec 15;181(12):8194-8
pubmed: 19050234
Int J Gynaecol Obstet. 2003 Dec;83(3):307-8
pubmed: 14643045
Electrophoresis. 2005 Jul;26(14):2797-808
pubmed: 15981297
J Oral Pathol Med. 2001 Oct;30(9):553-9
pubmed: 11555159
Cell Microbiol. 2013 May;15(5):701-8
pubmed: 23253282
BMC Infect Dis. 2014 Apr 08;14:188
pubmed: 24712485
PLoS Pathog. 2014 Jun 19;10(6):e1004211
pubmed: 24945925
Methods Mol Biol. 2009;470:105-23
pubmed: 19089380
Microbiology (Reading). 2019 Oct;165(10):1041-1060
pubmed: 31050635
Nat Protoc. 2006;1(6):2767-73
pubmed: 17406503
J Am Soc Mass Spectrom. 1999 Jan;10(1):45-54
pubmed: 9888184
Front Immunol. 2020 Dec 08;11:507092
pubmed: 33363530
Nucleic Acids Res. 2017 Jan 4;45(D1):D592-D596
pubmed: 27738138
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7628-33
pubmed: 17456602
Infect Immun. 2010 Mar;78(3):1066-77
pubmed: 20008535
J Biol Chem. 2010 Feb 12;285(7):4826-36
pubmed: 20018855
J Dent Res. 1999 Apr;78(4):857-68
pubmed: 10326730
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Yale J Biol Med. 2017 Jun 23;90(2):291-300
pubmed: 28656015
APMIS. 1999 Nov;107(11):971-81
pubmed: 10598868
Mucosal Immunol. 2014 May;7(3):684-93
pubmed: 24172847
Mycopathologia. 2011 Dec;172(6):415-27
pubmed: 21769633
Am J Pathol. 2015 Jun;185(6):1624-37
pubmed: 25864926
Methods Mol Biol. 2013;979:65-70
pubmed: 23397389
Biochim Biophys Acta. 2003 May 12;1640(2-3):119-28
pubmed: 12729921
Cell Microbiol. 2015 Mar;17(3):389-407
pubmed: 25287304
Clin Lab. 2013;59(9-10):945-52
pubmed: 24273915
Front Microbiol. 2017 Jun 08;8:1055
pubmed: 28642757
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
F1000Res. 2020 Apr 28;9:304
pubmed: 32489650
Infect Immun. 2013 Oct;81(10):3503-14
pubmed: 23836822
PLoS Pathog. 2007 Sep 28;3(9):1195-207
pubmed: 17845073
Nature. 2013 May 30;497(7451):633-7
pubmed: 23665962
Eukaryot Cell. 2004 Apr;3(2):546-52
pubmed: 15075283
Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):E8628-E8636
pubmed: 28973876
mBio. 2021 Jun 29;12(3):e0053121
pubmed: 34154403
FEBS Lett. 2008 Jun 11;582(13):1783-7
pubmed: 18474236
PLoS One. 2011 Feb 23;6(2):e17046
pubmed: 21407800
Front Physiol. 2014 Aug 12;5:299
pubmed: 25161624
Front Immunol. 2020 Jan 31;10:3147
pubmed: 32082307
Database (Oxford). 2018 Jan 1;2018:
pubmed: 30576484
mBio. 2020 Apr 21;11(2):
pubmed: 32317324
Lancet. 2007 Jun 9;369(9577):1961-71
pubmed: 17560449
Zentralbl Bakteriol Mikrobiol Hyg A. 1983 Nov;255(4):537-48
pubmed: 6197827
Dis Model Mech. 2019 Sep 12;12(9):
pubmed: 31413153
Mol Gen Genet. 1984;198(2):179-82
pubmed: 6394964
J Exp Med. 2004 Nov 1;200(9):1213-9
pubmed: 15504822
mBio. 2018 Jun 5;9(3):
pubmed: 29871918
Food Chem. 2014 Feb 15;145:90-4
pubmed: 24128453
Postgrad Med. 2013 May;125(3):33-46
pubmed: 23748505
Cell Host Microbe. 2020 Sep 9;28(3):411-421.e6
pubmed: 32526159
J Fungi (Basel). 2018 Oct 31;4(4):
pubmed: 30384449
Infect Immun. 2017 Aug 18;85(9):
pubmed: 28630071
Front Cell Infect Microbiol. 2018 Jun 05;8:185
pubmed: 29922600
BMC Womens Health. 2019 Mar 29;19(1):48
pubmed: 30925872
Nat Med. 2007 Jul;13(7):778-80
pubmed: 17618263
J Proteome Res. 2007 Jul;6(7):2874-83
pubmed: 17539673
Nature. 2016 Apr 7;532(7597):64-8
pubmed: 27027296
Diagn Microbiol Infect Dis. 2005 Aug;52(4):285-93
pubmed: 15893902
Cell Metab. 2018 May 01;27(5):988-1006.e7
pubmed: 29719235
J Infect Dis. 1997 Mar;175(3):661-8
pubmed: 9041339
mSphere. 2020 May 13;5(3):
pubmed: 32404511
Am J Obstet Gynecol. 1998 Feb;178(2):203-11
pubmed: 9500475
EMBO Rep. 2006 Sep;7(9):880-5
pubmed: 16953201
BMC Genomics. 2011 Apr 15;12:192
pubmed: 21496229

Auteurs

Marina Pekmezovic (M)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.

Ann-Kristin Kaune (AK)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.

Sophie Austermeier (S)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.

Sophia U J Hitzler (SUJ)

Junior Research Group Adaptive Pathogenicity Strategies, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.

Selene Mogavero (S)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.

Hrant Hovhannisyan (H)

Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Spain.
Mechanisms of Disease Department, Institute for Research in Biomedicine (IRB), Barcelona, Spain.

Toni Gabaldón (T)

Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Spain.
Mechanisms of Disease Department, Institute for Research in Biomedicine (IRB), Barcelona, Spain.
Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

Mark S Gresnigt (MS)

Junior Research Group Adaptive Pathogenicity Strategies, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.

Bernhard Hube (B)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.
Institute of Microbiology, Friedrich Schiller University, Jena, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH